These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31181310)
1. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma. Yang H; Liu Y; Qiu Y; Ding M; Zhang Y Int J Pharm; 2019 Jul; 566():585-593. PubMed ID: 31181310 [TBL] [Abstract][Full Text] [Related]
2. Combination of Oxaliplatin and Vit.E-TPGS in Lipid Nanosystem for Enhanced Therapeutic Efficacy in Colon Cancers. Wang Y; Zhang X; Zhang W; Dong H; Zhang W; Mao J; Dai Y Pharm Res; 2018 Jan; 35(2):27. PubMed ID: 29368145 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation. Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300 [TBL] [Abstract][Full Text] [Related]
4. Anti-miRNA21 and resveratrol-loaded polysaccharide-based mesoporous silica nanoparticle for synergistic activity in gastric carcinoma. Hu Y; Wang Z; Qiu Y; Liu Y; Ding M; Zhang Y J Drug Target; 2019 Dec; 27(10):1135-1143. PubMed ID: 31017473 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer. Jiang H; Shi X; Yu X; He X; An Y; Lu H Pharm Res; 2018 Feb; 35(4):73. PubMed ID: 29476264 [TBL] [Abstract][Full Text] [Related]
6. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study. Ahmed F; Kumari S; Kondapi AK Pharm Res; 2018 Jul; 35(9):178. PubMed ID: 30014319 [TBL] [Abstract][Full Text] [Related]
8. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis. Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690 [TBL] [Abstract][Full Text] [Related]
11. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model. Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839 [TBL] [Abstract][Full Text] [Related]
12. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties. Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595 [TBL] [Abstract][Full Text] [Related]
13. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies. Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150 [TBL] [Abstract][Full Text] [Related]
14. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657 [TBL] [Abstract][Full Text] [Related]
15. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging. Zhao Q; Wang S; Yang Y; Li X; Di D; Zhang C; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():475-484. PubMed ID: 28576012 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy. Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424 [TBL] [Abstract][Full Text] [Related]
18. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy. Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434 [TBL] [Abstract][Full Text] [Related]
19. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471 [TBL] [Abstract][Full Text] [Related]